Puma Biotechnology (PBYI) Assets (2010 - 2026)
Puma Biotechnology's Assets was $192.74 million in Q2 2026, down 1.1% from $194.92 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Assets at Puma Biotechnology came in at $216.3 million, up 1.4% from FY2024.
- Assets shows a five-year compound annual growth rate of -2.4% (FY2020 to FY2025).
- In earlier years, Assets was $213.33 million in FY2024 (-7.5%), $230.53 million in FY2023 (+3.8%), $222.06 million in FY2022 (-2.0%) and $226.59 million in FY2021 (-7.2%).
- Quarterly Assets has moved between $192.7 million (Q1 2026) and $230.53 million (Q4 2023) over five years.
- Compared with a year earlier, Assets was higher in two of the last eight quarters, with an average decline of 2.7%.
- The best year-over-year quarter for Assets over five years was Q1 2024 (growth of 9.1%); the worst was Q2 2022 (a decline of 25.5%).
- Per Business Quant data, PBYI's Assets in the three quarters before Q2 2026 was $192.7 million (Q1 2026), $216.3 million (Q4 2025) and $202.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Puma Biotechnology | 429.94 Mn | 42.58 Mn | 44.03 Mn | 192.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 192.74 Mn |
| Mar 31, 2026 | 192.70 Mn |
| Dec 31, 2025 | 216.30 Mn |
| Sep 30, 2025 | 202.86 Mn |
| Jun 30, 2025 | 194.92 Mn |
| Mar 31, 2025 | 196.18 Mn |
| Dec 31, 2024 | 213.33 Mn |
| Sep 30, 2024 | 220.72 Mn |
| Jun 30, 2024 | 205.00 Mn |
| Mar 31, 2024 | 214.15 Mn |
| Dec 31, 2023 | 230.53 Mn |
| Sep 30, 2023 | 203.61 Mn |
| Jun 30, 2023 | 200.49 Mn |
| Mar 31, 2023 | 196.26 Mn |
| Dec 31, 2022 | 222.06 Mn |
| Sep 30, 2022 | 198.77 Mn |
| Jun 30, 2022 | 193.65 Mn |
| Mar 31, 2022 | 200.69 Mn |
| Dec 31, 2021 | 226.59 Mn |
| Sep 30, 2021 | 226.29 Mn |
API Access
Puma Biotechnology Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();